A recent article in Huff Post Business highlighted Mettrum Health Corp. (TSXV:MT.V), a vertically integrated provider of cannabis products located in Bowmanville, Ontario.
As quoted in the article:

Mettrum’s licensed production facilities span over 80,000 square feet of capacity, located on a total of over 80 acres of land. The Bowmanville location (one of two) is massive, and houses their client service team and part of the grow operations. We passed through a number of security checkpoints — something they take very seriously (maybe even more so than the Canadian government requires).
A good fact to note: I was informed that the entire process takes about three months from clone to harvest. It was fascinating to see the complexity of the operation — almost otherworldly — where each plant has a dedicated lamp and computer-automated filtration system in their grow pod for consistency and potency of supplemental nutrients.
Afterwards, we toured Mettrum’s extraction lab where their concentrated oils are produced. Mettrum’s cannabis oils were designed to address the demand from patients and health care professionals alike for alternative consumption methods of medical cannabis to exist. Since launching their oils in January of this year, Mettrum has witnessed firsthand the tremendous appetite for extracted products.
Touring these facilities made it obvious that medical-grade cannabis is way more than just a “medical marijuana” sign on a storefront. It would be very difficult to replicate what goes on inside these facilities without having the experience, real estate and capital to uphold such an impressive growing practice. I don’t care what anyone says, the proof is in the cannabis-infused pudding; patients who are looking to obtain safe medicine should highly consider doing so from a top-tier government regulated source that shows accountability to their product.

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less